Asia: Preferred Destination For Clinical Trials 2020
Account upgrade
The download is free, but we offer some paid services. Support us by subscribing
Delete ads and speed up browsing the library.
The download starts with the click of a button without waiting for the book to be ready.
No limits for download times.
You can upload unlimited books in the library.
Enable readers to download your books without waiting.
Delete ads on the books that you publish.
No problems with download links for your uploaded books.
Download Book Asia Preferred Destination For Clinical Trials 2020 Pdf
Asia: Preferred Destination For Clinical Trials 2020
| Author: | A Frost & Sullivan Whitepaper |
| Category: | Research Methodology [Edit] |
| Language: | English |
| Pages: | 24 |
| File Size: | 989.82 KB |
| Extension: | |
| Creation Date: | 11 Mar 2020 |
| Rank: | 846,866 No 1 most popular |
| Short link: | Copy |
| More books like this book | |
Mohamed Irhuma
Professor
The Publisher and not the author Book Asia: Preferred Destination For Clinical Trials 2020 .
As a Professor in Clinical Pharmacology, an academic researcher, and a physician, my professional journey has uniquely positioned me at the nexus of scientific rigour and holistic well-being. My work transcends conventional medical boundaries, delving into the philosophical underpinnings of Islamic thought, particularly as they relate to human health and spiritual [Imaan] flourishing. My research often explores how the sacred Islamic principles, such as those found in the rich Prophetic Sunnah, can inform contemporary medical ethics and practice. I aim to offer a nuanced perspective on healing that encompasses both body and soul [Imaan], acknowledging the Sunnah's role as a "divinely preserved legacy" that "elucidates the Qur’an’s commands" and guides a complete way of life. This interdisciplinary approach, deeply rooted in both empirical science and the true rich heritage of Islamic philosophy, underpins my writing, bridging the gap between faith [ISLAM] and evidence-based knowledge.
Book Description
The global biopharmaceutical sector continues its strong growth, largely fuelled
by requirements for new innovative medical products, ageing populations, and growth in demand from developing economies.
In 2018, global spending on medicines approached $1.3 trillion1 and is expected to
grow at 5% per annum to reach $1.6 trillion by 2022. Global data, however, masks
significant regional variations, with the fastest growth set to occur in
“pharmerging” markets, particularly in Asia-Pacific. China is now the world’s
second-largest medicines market, with spending of $137 billion in 2018, up $40
billion from a decade earlier. Although growth in medicines spending in China has
slowed in recent years, it is forecast to increase by about 6% per annum, well
ahead of markets in North America and Europe.2 Significant growth is also projected in markets such as India, Thailand, the
Philippines, and Vietnam, indicating the increasing importance of Asian markets in
the global biopharma sector.
Share the book :
Book Review "Asia: Preferred Destination For Clinical Trials 2020"
Book Quotes "Asia: Preferred Destination For Clinical Trials 2020"
Other books like "Asia: Preferred Destination For Clinical Trials 2020"
If there is a problem with the book, please report through one of the following links:
Report the book or by Contact us
E-books are complementary and supportive of paper books and never cancel it. With the click of a button, the e-book reaches anyone, anywhere in the world.
E-books may weaken your eyesight due to the glare of the screen. Support the book publisher by purchasing his original paper book. If you can access it and get it, do not hesitate to buy it.
Publish your book now for free
